Melissa Stockwell, MD MPH
Columbia University
14
14
14
N/A
0
8
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+4 more interventions
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (14)
Showing 10 of 14 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Philip LaRussa, MD
Columbia University
Shared therapeutic areas:
Worked with same sponsors:
Alex Fiks, MD MSCE
Children's Hospital of Philadelphia
Shared therapeutic areas:
Worked with same sponsors:
Karen Broder, MD
Centers for Disease Control and Prevention
Shared therapeutic areas:
Worked with same sponsors:
Maria Cano, MD MPH
Centers for Disease Control and Prevention
Shared therapeutic areas:
Worked with same sponsors:
Steven Shea, MD, MS
Columbia University
Shared therapeutic areas:
Worked with same sponsors:
Steven Shea, MD MS
Columbia University
Shared therapeutic areas:
Worked with same sponsors:
Jessica Singer, MD MPH
Columbia University
Shared therapeutic areas:
Worked with same sponsors:
Novartis vaccines and Diagnostics
Novartis Vaccines
Shared therapeutic areas:
Seetha Shankaran, MD
Wayne State University
Shared therapeutic areas:
Worked with same sponsors:
Abhik Das, PhD
RTI International
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (14)
Showing 14 of 14 trials
Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season
Influenza Vaccine Randomized Educational Trial: Adult
Influenza Vaccine Attitudes, Intent, and Receipt: Pediatric
FeverText: Assessing Fever Rates After Vaccination During the 2011-12 Influenza Season Using Text Messaging
Vaccine Health Literacy Related Text Message Reminders to Increase Receipt of Second Dose of Influenza Vaccine for Young, Low Income, Urban Children
Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014
Appropriate Care of URI (ACURI): Early Head Start
Adult Influenza Vaccination Text Message Reminders
PregText: Feasibility of Monitoring Influenza Vaccine Safety in Pregnant Women Using Text Messaging
Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts
Fever and Wheezing Events in Children After US Influenza Vaccines Using Text Messaging
All 14 trials loaded